Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Explore highly rated travel credit cards that come with no fees. Maximize your travel rewards while minimizing costs.
22,733 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Union electricians rely on a layered, hour-based pension system that can shortchange retirees if filings, vesting, or...
When a mining stock dropped today, investors often wonder what behind-the-scenes factors pushed the move. This guide ...
Record first-quarter funding in defense technology heightens concerns that the defense tech boom become a bubble. Val...
The Supreme Court curtailed presidential tariffs, triggering market volatility and warnings of a coming financial mes...
President Trump disclosed a $2.2 billion 2025 income, including roughly $1 billion from crypto. Washington’s ethics e...
A tech-focused investor known for hunting winners, billionaire Philippe Laffont just rotated from a high-profile AI p...
DeepMind’s 2010 seed and Google’s 2014 buyout sparked debate about exit timing in AI. This report weighs whether the ...
Stock splits often signal strong momentum. Here are three stock-split stocks before they soar, with practical analysi...
Bitcoin’s Q2 move coincided with a rare drop in stablecoins, underscoring a broader liquidity squeeze as BTC fell and...
Palo Alto Networks has seen a meaningful pullback, but a dip can become a doorway for patient investors. This guide b...
Tesla reports a robust quarter with deliveries around 515,000, topping expectations and reigniting investor optimism....